"The BlissCo team is committed to building value for our investors, partners, team and customers. By listing on the Frankfurt Stock Exchange, we are making it easier for international investors to participate in our growth. The Frankfurt Stock Exchange is the leading exchange in the German and European markets," said Damian Kettlewell, BlissCo CEO.

The Frankfurt Stock Exchange is used by over 250 trading institutions and ranks third globally in trade volume, following only the New York Stock Exchange and NASDAQ.

About BlissCo Cannabis Corp

BlissCo (CSE: BLIS) (FRA: GQ4B) earned its Access to Cannabis for Medical Purposes Regulation ACMPR License to Cultivate on Thursday, March 29, 2018. BlissCo's ACMPR facility in Langley, B.C. is designed to be a high-volume packager, processor and distributor of premium medical cannabis and adult use cannabis when it is legal in Canada, which is currently anticipated to be August 2018 at the earliest. BlissCo has a two-year supply agreement with The Supreme Cannabis Company Inc (TSX.V: FIRE) to purchase 3,000 kilograms of premium whole dried cannabis flower.

BlissCo will apply to expand its licenses to include medical cannabis oil production and medical cannabis sales in Q2 2018. BlissCo will focus on high volume sales opportunities in the regulated medical use and adult use cannabis market in Canada when it is legal and is pursuing expansion opportunities in international markets.

On Behalf of the Board of Directors

BLISSCO CANNABIS CORP.

Damian Kettlewell, CEO, Founder & Chair

Cautionary Statement

This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation (collectively "forward-looking statements"). The use of any of the word "will" and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Such forward-looking statements should not be unduly relied upon. This news release contains forward-looking statements and assumptions pertaining to the following: the ability to execute on our strategic plans and the impact on our future operations, capital expenditures, receipt of a cannabis oil license and a license to sell dried cannabis and other objectives. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors. The Company believes the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct. The Company does not undertake to update these forward-looking statements, except as required by law.

The CSE has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.

SOURCE BlissCo Cannabis Corp.

For further information: Damian Kettlewell, CEO, (604) 484 9119, ext. 3, [email protected]